Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana School of Medicine
Indianapolis, Indiana, 46202, United States
NCT Number: NCT02959593
To determine the relationship between the affects of viewing commercially available content through the VISIOR video goggles and ocular blood flow in glaucoma patients and healthy subjects.
Looking for future studies?
Notify Me30 year and older
All sexes
Interventional
Not applicable
Indianapolis, Indiana, 46202, United States
To determine if glaucoma patients and healthy subject experience any alteration in localized retinal blood flow after retinal stimulation by viewing commercially available content through the VISIOR video goggles.
Both groups will undergo measurements of arterial blood pressure, cardiac pulse (heart rate), intraocular pressure, and retinal blood flow using Heidelberg retinal flowmetry (Heidelberg Engineering, Heidelberg, Germany) at baseline and then ten minutes, thirty minutes, and sixty minutes after viewing commercially available content through the VISIOR video goggles for thirty minutes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
View commercially available content through the VISIOR video goggles continuously for thirty minutes.
Time frame: 1 day
retinal capillary blood flow in arbitrary units
Visior Technologies Ltd.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06144918
Eye Diseases, Glaucoma
Glendale, California, United States
View Trial DetailsNCT06978101
Chorioretinal Changes, Eye Diseases
Asyut, Egypt
View Trial DetailsNCT04830397
Eye Diseases, Glaucoma
Albany, Georgia, United States
View Trial DetailsNCT06745856
Eye Diseases, Glaucoma
View Trial Details